Profile
BSX-PA ABT SYK MDT BSX EW
Company Name Boston Scientific Corporation Abbott Laboratories Stryker Corporation Medtronic plc Boston Scientific Corporation Edwards Lifesciences Corporation
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $175.45B $196.11B $139.91B $127.61B $110.83B $44.88B
Employees 45.00K 114.00K 53.00K 95.00K 53.00K 15.80K
CEO Michael F. Mahoney Robert Ford Kevin A. Lobo Geoffrey Straub Martha Michael F. Mahoney Bernard J. Zovighian
Ratings
BSX-PA ABT SYK MDT BSX EW
Quant Rating Score 2 3 3 1 1
Quant Rating Sell Neutral Neutral Strong Sell Strong Sell
Trading
BSX-PA ABT SYK MDT BSX EW
Last Close $122.18 $130.03 $360.13 $96.28 $101.76 $84.74
High 52 $122.18 $140.22 $403.53 $98.43 $108.14 $86.3
Low 52 $122.18 $111.1 $337.28 $79.61 $88.03 $67.08
Price vs. 52 Week High 0 % -7.27 % -10.76 % -2.18 % -5.9 % -1.81 %
Price vs. 52 Week Low 0 % 17.04 % 6.77 % 20.94 % 15.6 % 26.33 %
Total Return
BSX-PA ABT SYK MDT BSX EW
1 Month Return 0 % 1.16 % -3.82 % 0.52 % 2.54 % 13.53 %
3 Month Return 0 % -0.18 % -5.68 % 3.74 % -1.25 % 8.24 %
6 Month Return 0 % -3.54 % -8.65 % 11.38 % -4.04 % 8.64 %
9 Month Return 0 % -0.12 % -6.61 % 11.86 % -3.41 % 11.99 %
YTD Return 0 % 14.96 % 0.02 % 20.53 % 13.93 % 14.47 %
1 Year Return 0 % 11.01 % -7.35 % 13.27 % 12.65 % 20.71 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BSX-PA ABT SYK MDT BSX EW
Dividend Yield Percentage (TTM) - 2.13 % 0.93 % 2.84 % - -
Dividend Paid and Capex Coverage Ration (TTM) 5.44 % 1.46 % 2.47 % 1.29 % 5.44 % 4.78 %
Dividend Per Share (TTM) - 2.4 % 3.4 % 2.83 % - -
Payout Ratio (TTM) - 61.99 % 39.56 % 75.84 % - -
Profitability
BSX-PA ABT SYK MDT BSX EW
Gross Profit Margin TTM 69.01 % 55.51 % 63.54 % 62.27 % 69.01 % 78.07 %
Return on Assets TTM 6.77 % 7.75 % 6.78 % 5.22 % 6.77 % 8.06 %
Return on Equity TTM 12.87 % 13.18 % 15.04 % 9.83 % 12.87 % 10.47 %
Return on Capital Employed TTM 10.62 % 11.56 % 14.07 % 7.63 % 10.62 % -0.58 %
Net Income Per EBT TTM 85.38 % 77.06 % 71.91 % 83.61 % 85.38 % 84.07 %
EBT Per Ebit TTM 85.24 % 105.19 % 80.09 % 91.74 % 85.24 % -1894.2 %
EBIT Per Revenue TTM 19.78 % 18.16 % 22.44 % 17.87 % 19.78 % -1.11 %
Cash Flow To Debt Ratio TTM 38.4 % 70.47 % 33.95 % 24.44 % 38.4 % 145.19 %
Receivables Turnover TTM 7.1 4.26 6.22 5.44 7.1 6.8
Payables Turnover TTM 6.21 4.78 - 5.08 6.21 8.08
Inventory Turnover TTM 2.13 2.94 1.72 2.13 2.13 1.17
Fixed Asset Turnover TTM 468.06 % 385.33 % 647.99 % 485.18 % 468.06 % 329.8 %
Asset Turnover TTM 47.01 % 52.66 % 52.5 % 38.05 % 47.01 % 45.72 %
Operating Cash Flow Per Share TTM 3.12 5.22 13.19 5.55 3.12 1.75
Free Cash Flow Per Share TTM 2.55 3.96 11.2 4.06 2.55 1.39
Cash Per Share TTM 85.99 % 442.64 % 1071.9 % 649.63 % 85.99 % 661.96 %
Operating Cash Flow Sales Ratio TTM 23.04 % 20.57 % 20.08 % 20.46 % 23.04 % 16.76 %
Free Cash Flow Operating Cash Flow Ratio TTM 81.6 % 75.85 % 84.91 % 73.19 % 81.6 % 79.09 %
Cash Flow Coverage Ratios TTM 38.4 % 70.47 % 33.95 % 24.44 % 38.4 % 145.19 %
Price To Free Cash Flows Ratio TTM 29.17 28.35 32.67 24.51 29.36 55.8
Price To Operating Cash Flows Ratio TTM 23.8 21.59 27.74 17.93 23.95 43.63
Price Cash Flow Ratio TTM 23.8 21.59 27.74 17.93 23.95 43.63
Income Statement (TTM)
BSX-PA ABT SYK MDT BSX EW
Revenue $20.07B $44.33B $25.12B $33.54B $20.07B $6.07B
Gross Profit $13.85B $24.61B $15.43B $21.91B $13.85B $4.74B
Gross Profit Ratio 69.01% 55.51% 61.44% 65.32% 69.01% 78.13%
EBITDA $3.73B $11.33B $5.69B $9.22B $3.73B $1.27B
Net Income $2.89B $6.52B $3.25B $4.66B $2.89B $1.07B
EPS Diluted 1.94 3.72 8.4 3.61 1.94 1.83
Balance Sheet (MRQ)
BSX-PA ABT SYK MDT BSX EW
Long Term Debt $9.37B $13.52B $14.86B $25.64B $9.37B $0.68B
Total Liabilities $17.39B $33.51B $25.42B $43.42B $17.39B $2.99B
Total Equity $22B $47.9B $22.42B $48.26B $22B $10.06B
Total Investments $0.56B $1.24B $0.09B $6.75B $0.56B $1.24B
Total Debt $11.15B $15.28B $14.86B $28.52B $11.15B $0.7B
Total Assets $39.4B $81.41B $47.84B $91.68B $39.4B $13.06B
Cash Flow Statement (TTM)
BSX-PA ABT SYK MDT BSX EW
Net Income $1.85B $13.4B $3.25B $4.69B $1.85B $4.17B
Inventory $-0.23B $-0.06B $0B $-0.29B $-0.23B $-0.26B
Dividends Paid $0B $-3.84B $-1.28B $-3.59B $0B $0B
Operating Cash Flow $3.44B $8.56B $5.04B $7.04B $3.44B $0.54B
Capital Expenditure $-0.79B $-2.21B $-0.76B $-1.86B $-0.79B $-0.25B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 112.68
ADGM Adagio Medical Holdings, Inc. 0.985
AEMD Aethlon Medical, Inc. 1.96
AFIB Acutus Medical, Inc. 0.0002
AHCO AdaptHealth Corp. 10.2
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 186.77
ALUR Allurion Technologies Inc. 1.12
AMIX Autonomix Medical, Inc. Common Stock 0.3833
ANIK Anika Therapeutics, Inc. 10.21
AORT Artivion, Inc. 36.6
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 3.72
ARAY Accuray Incorporated 0.5476
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 13.36
AVNS Avanos Medical, Inc. 14.9
AVR Anteris Technologies Global Corp. Common Stock 5.71
AXDX Accelerate Diagnostics, Inc. 0.034
Unlock